Rutulkumar Patel1, Luchang Zhang2, Amar Desai3, Mark J Hoenerhoff4, Lucy H Kennedy4, Tomas Radivoyevitch5, Chiara La Tessa6, Stanton L Gerson7, Scott M Welford8. 1. Department of Radiation Oncology, Duke University, Durham, North Carolina. 2. Department of Medicine, Case Western Reserve University, Cleveland, Ohio. 3. Department of Medicine, Case Western Reserve University, Cleveland, Ohio; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. 4. Unit for Laboratory Animal Medicine, University of Michigan, Ann Arbor, Michigan. 5. Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio. 6. University of Trento, Trento, Italy; Trento Institute for Fundamental Physics and Applications TIFPA-INFN, Trento, Italy. 7. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. 8. Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida; Department of Radiation Oncology, University of Miami, Miami, Florida. Electronic address: scott.welford@med.miami.edu.
Abstract
PURPOSE: Humans are exposed to charged particles in different scenarios. The use of protons and high-linear energy transfer (LET) in cancer treatment is steadily growing. In outer space, astronauts will be exposed to a mixed radiation field composed of both protons and heavy ions, in particularly the long-term space missions outside of earth's magnetosphere. Thus, understanding the radiobiology and transforming potential of these types of ionizing radiation are of paramount importance. METHODS AND MATERIALS: We examined the effect of 10 or 100 cGy of whole-body doses of protons or 28Si ions on the hematopoietic system of a genetic model of aging based on recent studies that showed selective loss of the MLH1 protein in human hematopoietic stems with age. RESULTS: We found that Mlh1 deficient animals are highly prone to develop lymphomas when exposed to either low doses of protons or 28Si ions. The lymphomas that develop are genetically indistinguishable, in spite of different types of damage elicited by low- and high-LET radiation. RNA sequencing analyses reveal similar gene expression patterns, similar numbers of altered genes, similar numbers of single nucleotide variants and insertions and deletions, and similar activation of known leukemogenic loci. CONCLUSIONS: Although the incidence of malignancy is related to radiation quality, and increased due to loss of Mlh1, the phenotype of the tumors is independent of LET.
PURPOSE:Humans are exposed to charged particles in different scenarios. The use of protons and high-linear energy transfer (LET) in cancer treatment is steadily growing. In outer space, astronauts will be exposed to a mixed radiation field composed of both protons and heavy ions, in particularly the long-term space missions outside of earth's magnetosphere. Thus, understanding the radiobiology and transforming potential of these types of ionizing radiation are of paramount importance. METHODS AND MATERIALS: We examined the effect of 10 or 100 cGy of whole-body doses of protons or 28Si ions on the hematopoietic system of a genetic model of aging based on recent studies that showed selective loss of the MLH1 protein in human hematopoietic stems with age. RESULTS: We found that Mlh1 deficient animals are highly prone to develop lymphomas when exposed to either low doses of protons or 28Si ions. The lymphomas that develop are genetically indistinguishable, in spite of different types of damage elicited by low- and high-LET radiation. RNA sequencing analyses reveal similar gene expression patterns, similar numbers of altered genes, similar numbers of single nucleotide variants and insertions and deletions, and similar activation of known leukemogenic loci. CONCLUSIONS: Although the incidence of malignancy is related to radiation quality, and increased due to loss of Mlh1, the phenotype of the tumors is independent of LET.
Authors: F A Cucinotta; W Schimmerling; J W Wilson; L E Peterson; G D Badhwar; P B Saganti; J F Dicello Journal: Radiat Res Date: 2001-11 Impact factor: 2.841
Authors: J F Dicello; A Christian; F A Cucinotta; D S Gridley; R Kathirithamby; J Mann; A R Markham; M F Moyers; G R Novak; S Piantadosi; R Ricart-Arbona; D M Simonson; J D Strandberg; M Vazquez; J R Williams; Y Zhang; H Zhou; D Huso Journal: Phys Med Biol Date: 2004-08-21 Impact factor: 3.609
Authors: Andreas M Stark; Alexander Doukas; Heinz-Herrmann Hugo; Jürgen Hedderich; Kirsten Hattermann; H Maximilian Mehdorn; Janka Held-Feindt Journal: Neurol Res Date: 2014-07-04 Impact factor: 2.448
Authors: Michael M Weil; F Andrew Ray; Paula C Genik; Yongjia Yu; Maureen McCarthy; Christina M Fallgren; Robert L Ullrich Journal: PLoS One Date: 2014-08-15 Impact factor: 3.240
Authors: Alexandra Rundberg Nilsson; Shamit Soneji; Sofia Adolfsson; David Bryder; Cornelis Jan Pronk Journal: PLoS One Date: 2016-07-01 Impact factor: 3.240
Authors: Rosa Drago-Ferrante; Riccardo Di Fiore; Fathi Karouia; Yashwanth Subbannayya; Saswati Das; Begum Aydogan Mathyk; Shehbeel Arif; Ana Paula Guevara-Cerdán; Allen Seylani; Aman Singh Galsinh; Weronika Kukulska; Joseph Borg; Sherif Suleiman; David Marshall Porterfield; Andrea Camera; Lane K Christenson; April Elizabeth Ronca; Jonathan G Steller; Afshin Beheshti; Jean Calleja-Agius Journal: Int J Mol Sci Date: 2022-07-05 Impact factor: 6.208